A Trial of Degarelix in Patients With Prostate Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00946920

Extrait

A phase 3, open-label, parallel group, one year trial comparing the efficacy and safety of degarelix 3-month depot with the established therapy goserelin acetate 3-month implant in patients with prostate cancer.


Critère d'inclusion

  • Prostate cancer


Liens